Clinical Trial Update: Multi-center Evaluation of the VERSANT® CT/GC DNA 1.0 Assay (kPCR)in Detecting C. Trachomatis and N. Gonorrhoeae

View source ↗

Summary

A multi-center evaluation of the VERSANT CT/GC DNA 1.0 assay for detecting Chlamydia trachomatis and Neisseria gonorrhoeae was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chlamydia Infection
• Gonorrhea

Drugs mentioned

• VERSANT CT/GC DNA 1.0 Assay (CT/GC DNA 1.0 assay)

Snippet

Sponsor: Siemens Healthcare Diagnostics Inc | Conditions: Chlamydia, Gonorrhea | Status: TERMINATED